<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04829227</url>
  </required_header>
  <id_info>
    <org_study_id>Sofwave05</org_study_id>
    <nct_id>NCT04829227</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Sofwave Treatment to Lift Lax Skin</brief_title>
  <official_title>Safety and Efficacy of Sofwave Treatment to Lift Lax Skin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sofwave Medical LTD</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sofwave Medical LTD</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open-label, non-randomized 2 arms prospective, multi-center, self-controlled clinical study&#xD;
      with masked evaluation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a two-arm study. Eligible patients will receive 2-4 face and/or neck and/or&#xD;
      submental or &quot;off the face&quot; (abdomen, or arms, or thighs, or Décolleté) treatments (per PI&#xD;
      discretion, 2-12 weeks apart) using the Sofwave System. In arm 1, each investigational site&#xD;
      would treat the full face and/or neck and/or submental zones including 1. -The forehead and&#xD;
      temples (left and right including the peri orbital zone) to lift the eyebrows 2. The cheeks&#xD;
      (left and right including perioral zone and nasolabial folds) 3. Submental and sides of the&#xD;
      neck (left and right) to lift lax skin. In arm 2, each site would treat &quot;off the face&quot; areas:&#xD;
      abdomen, or arms or thighs or Décolleté. Each patient could be assigned to both arms.&#xD;
      Treatment may be administered after the enrollment and screening at the first visit or it may&#xD;
      occur at a later date following the enrollment and screening activities based on site&#xD;
      scheduling availabilities. All patients will return to the clinic for one follow up visitat3&#xD;
      months ± 2 weeks post last treatment (FU1) and a second optional visit at 2. 6 months ± 2&#xD;
      weeks post last treatment (FU2; optional). Each treatment visit will also serve as a follow&#xD;
      up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvements in lifting of lax tissue</measure>
    <time_frame>3 and 6 months post last treatment</time_frame>
    <description>as assessed by independent masked evaluators of pre and post treatment images.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Skin Laxity</condition>
  <arm_group>
    <arm_group_label>face and/or neck and/or submental zones</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the full face and/or neck and/or submental zones including 1. -The forehead and temples (left and right including the peri orbital zone) to lift the eyebrows 2. The cheeks (left and right including perioral zone and nasolabial folds) 3. Submental and sides of the neck</description>
  </arm_group>
  <arm_group>
    <arm_group_label>&quot;off the face&quot; areas</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>&quot;off the face&quot; areas: abdomen, or arms or thighs or Décolleté.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sofwave</intervention_name>
    <description>The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues.</description>
    <arm_group_label>&quot;off the face&quot; areas</arm_group_label>
    <arm_group_label>face and/or neck and/or submental zones</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Healthy female and male subjects between the ages 35-80.&#xD;
&#xD;
          2. Non-Smoker.&#xD;
&#xD;
          3. Fitzpatrick skin type I-VI.&#xD;
&#xD;
          4. Desire to lift lax skin in the neck and submental and/or to lift the brows.&#xD;
&#xD;
          5. Able and willing to comply with all visit, treatment and evaluation schedules and&#xD;
             requirements.&#xD;
&#xD;
          6. Able to understand and provide written Informed Consent&#xD;
&#xD;
          7. Women of child-bearing age are required to be using a reliable method of birth control&#xD;
             at least 3 months prior to study enrollment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant or planning to become pregnant, having given birth less than 3 months ago,&#xD;
             and/or breast feeding.&#xD;
&#xD;
          2. Presence of any active systemic or local infections.&#xD;
&#xD;
          3. Presence of active local skin disease that may alter wound healing.&#xD;
&#xD;
          4. Severe solar elastosis.&#xD;
&#xD;
          5. History of smoking in past 10 years.&#xD;
&#xD;
          6. History of chronic drug or alcohol abuse.&#xD;
&#xD;
          7. Excessive subcutaneous fat on the cheeks.&#xD;
&#xD;
          8. Significant scarring in the area to be treated.&#xD;
&#xD;
          9. Severe or cystic facial acne, acutance uses during past 6 months.&#xD;
&#xD;
         10. Presence of a metal stent or implant in the facial area (dental implants and/or braces&#xD;
             are not excluded).&#xD;
&#xD;
         11. Inability to understand the protocol or to give informed consent.&#xD;
&#xD;
         12. History of cosmetic treatments in the facial area to be treated, including facial&#xD;
             skin-tightening procedure within the 6 months ; injectable (Botox or fillers) of any&#xD;
             type within the 6 months; ablative or non-ablative resurfacing/rejuvenation laser&#xD;
             treatment or light treatment within the past 6 months, dermabrasion or deep facial&#xD;
             peels within the past 12 months; facelift, blepharoplasty, or brow lift (including&#xD;
             contour threads) within the past 12 months.&#xD;
&#xD;
         13. Taking Isotretinoin or other oral retinoid within the past 6 months; taking&#xD;
             anti-platelet or anti-coagulant within the past 2 weeks.&#xD;
&#xD;
         14. As per the investigator's discretion, any physical or mental condition which might&#xD;
             make it unsafe for the subject to participate in this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruthie Amir, MD</last_name>
    <role>Study Director</role>
    <affiliation>Sofwave</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ruthie Amir, MD</last_name>
    <phone>+972-4-6432994</phone>
    <email>ruthie@sofwave.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shlomit Mann, MSc</last_name>
    <phone>+972-4-6432994</phone>
    <email>shlomit@sofwave.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>SLSS, a Division of Schweiger Dermatology Group Research Office</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Aranzazu</last_name>
      <phone>201-951-0701</phone>
      <email>dianaa@skinandlasers.com</email>
    </contact>
    <investigator>
      <last_name>David Goldberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amy Tank, PA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Practice of Brian S. Biesman, MD</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Spear, CCRC</last_name>
      <phone>615-329-1110</phone>
      <email>amanda@drbiesman.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tennessee Clinical Research Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>McDaniel Institute of Aging Research</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23462</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Mazur</last_name>
      <phone>757-417-8300</phone>
      <email>CMazur@miaar.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Laxity Brow Lifting Skin Saggy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cutis Laxa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

